ISOLATED ANTIBODY, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, USES THEREOF FOR INHIBITING BAFF ACTIVITY IN A MAMMAL AND A METHOD OF DETECTING A BAFF-R POLYPEPTIDE BASED THEREON
Disclosed are nucleic acids encoding BAFF-R polypeptides, as well as antibodies to BAFF-R polypeptides and pharmaceutical compositions including same. Methods of treating tumorigenic and autoimmune conditions using the nucleic acids, polypeptides, antibodies and pharmaceuticals compositions of this invention are also provided.